Melioidosis vaccines: A systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposes
Background: Burkholderia pseudomallei is a Category B select agent and the cause of melioidosis. Research funding for vaccine development has largely considered protection within the biothreat context, but the resulting vaccines could be applicable to populations who are at risk of naturally acquire...
Saved in:
Main Authors: | Sharon J. Peacock, Direk Limmathurotsakul, Yoel Lubell, Gavin C K W Koh, Lisa J. White, Nicholas P J Day, Richard W. Titball |
---|---|
Other Authors: | Mahidol University |
Format: | Review |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/15115 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Consensus on the development of vaccines against naturally acquired melioidosis
by: Direk Limmathurotsakul, et al.
Published: (2018) -
The global impact and cost-effectiveness of a melioidosis vaccine
by: Nantasit Luangasanatip, et al.
Published: (2020) -
Melioidosis: A clinical overview
by: Direk Limmathurotsakul, et al.
Published: (2018) -
Short report: Patterns of organ involvement in recurrent melioidosis
by: Direk Limmathurotsakul, et al.
Published: (2018) -
Cost-effectiveness analysis of parenteral antimicrobials for acute melioidosis in Thailand
by: Viriya Hantrakun, et al.
Published: (2018)